# SUMATRIPTAN SUCCINATE
> **ANDA203322** · Abbreviated New Drug Application (Generic) · Sponsor: NORVIUM BIOSCIENCE · Approved 2014-04-14
## Drug
- **FDA Application Number:** ANDA203322
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** Sumatriptan Succinate
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** NORVIUM BIOSCIENCE
- **First approval:** 2014-04-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203322)
---
*MORVS · CC0 1.0*